登录

Lead Medical Snares ¥10M in Series A2 Financing

作者: Mailman 2020-05-26 12:45
立达融医
http://www.lidarongyi.cn
企业数据由 动脉橙 提供支持
医疗数据处理软件研发商 | A+轮 | 运营中
中国-北京
2020-05-25
融资金额:数千万人民币
SIG海纳亚洲
查看

According to 36Kr.com, Lead Medical, a medical technology company, has closed Series A2 financing of tens of millions, led by SIG with participation from Taya Venture Capital. Proceeds from this round will be used to expand the business of Lead Medical in the domestic market. In October 2019, Lead Medical completed a Series A1 financing of tens of millions.


In September 2019, Yaoli changed its name to Lead Medical and announced that it would expand the market in the medical data storage and application based on the existing business. 


Founded in 2015, Lead Medical started with medical data to solve the problem of data integration and complex procedures in medical work. It created a medical dictionary library of medical knowledge and clinical solutions from home and aboard. The data granularity is based on practical work. 


Lead Medical has successfully developed a system to meet the demand for integration of complete, standardized, and structured data in clinical work and enables all data to be collected at the same time. The system can improve work efficiency by up to 90% for medical staff.


Based on the in-depth research on the demands of different clinical applications, Lead Medical has successively developed the clinical diagnosis and treatment follow-up record system, medical data analysis system, patient management community and others, and provided a comprehensive solution of clinical services for a single department.


>>>>
About SIG China


SIG's China venture capital and private equity activities are operated through SIG China, LLLP (SAI) and its wholly foreign-owned enterprise (WFOE) based in Shanghai with a branch office in Beijing. The SIG China team seeks to commit the firm's capital to venture capital and private equity investments in China.


>>>>

About Taya Venture Capital


Founded in 1998, Taya Venture Capital is an early-stage focused VC firm, making investments in territories such as Taiwan. The company typically invests in tech companies specializing in areas like Virtual Reality, Augmented Reality. Its notable portfolio company is iStaging.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

谷歌风投、OrbiMed等多家顶级投资机构,他们在海外投什么医疗企业

Dongxi Tech Closes on Two Rounds of Financing to Provide Medical Security Cloud Service

新基也投了,医疗数据分析公司GNS Healthcare完成2300万美元D轮融资

【首发】心景科技A轮累计获得亿元融资,推动多款DTx产品商业化

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

双向征集项目和资本,SAPA健康投资论坛暨路演将在六月线上举行

2020-05-26
下一篇

Proprium Biotech Closes ¥10M Series A Funding Round

2020-05-26